Smartwatch monitoring for atrial fibrillation after stroke—The Pulsewatch Study: Protocol for a multiphase randomized controlled trial
Background: Atrial fibrillation (AF) is a common heart rhythm disorder that elevates stroke risk. Stroke survivors undergo routine heart rhythm monitoring for AF. Smartwatches are capable of AF detection and potentially can replace traditional cardiac monitoring in stroke patients. Objective: The go...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Cardiovascular Digital Health Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666693621000633 |
id |
doaj-954ae824cadf4affa31f83f901db52e9 |
---|---|
record_format |
Article |
spelling |
doaj-954ae824cadf4affa31f83f901db52e92021-08-14T04:31:58ZengElsevierCardiovascular Digital Health Journal2666-69362021-08-0124231241Smartwatch monitoring for atrial fibrillation after stroke—The Pulsewatch Study: Protocol for a multiphase randomized controlled trialEmily L. Dickson, BS0Eric Y. Ding, MS1Jane S. Saczynski, PhD2Dong Han, BS3Majaz Moonis, MD4Timothy P. Fitzgibbons, MD, PhD5Bruce Barton, PhD6Ki Chon, PhD7David D. McManus, MD, MSci, FHRS8College of Osteopathic Medicine, Des Moines University, Des Moines, IowaDepartment of Medicine, University of Massachusetts Medical School, Worcester, MassachusettsDepartment of Pharmacy and Health System Sciences, Northeastern University, Boston, MassachusettsDepartment of Biomedical Engineering, University of Connecticut, Storrs, ConnecticutDepartment of Medicine, University of Massachusetts Medical School, Worcester, MassachusettsDepartment of Medicine, University of Massachusetts Medical School, Worcester, MassachusettsDepartment of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MassachusettsDepartment of Biomedical Engineering, University of Connecticut, Storrs, ConnecticutCollege of Osteopathic Medicine, Des Moines University, Des Moines, Iowa; Address reprint requests and correspondence: Dr David D. McManus, 55 N Lake Avenue, Worcester, MA 01655.Background: Atrial fibrillation (AF) is a common heart rhythm disorder that elevates stroke risk. Stroke survivors undergo routine heart rhythm monitoring for AF. Smartwatches are capable of AF detection and potentially can replace traditional cardiac monitoring in stroke patients. Objective: The goal of Pulsewatch is to assess the accuracy, usability, and adherence of a smartwatch-based AF detection system in stroke patients. Methods: The study will consist of two parts. Part I will have 6 focus groups with stroke patients, caretakers, and physicians, and a Hack-a-thon, to inform development of the Pulsewatch system. Part II is a randomized clinical trial with 2 phases designed to assess the accuracy and usability in the first phase (14 days) and adherence in the second phase (30 days). Participants will be randomized in a 3:1 ratio (intervention to control) for the first phase, and both arms will receive gold-standard electrocardiographic (ECG) monitoring. The intervention group additionally will receive a smartphone/smartwatch dyad with the Pulsewatch applications. Upon completion of 14 days, participants will be re-randomized in a 1:1 ratio. The intervention group will receive the Pulsewatch system and a handheld ECG device, while the control group will be passively monitored. Participants will complete questionnaires at enrollment and at 14- and 44-day follow-up visits to assess various psychosocial measures and health behaviors. Results: Part I was completed in August 2019. Enrollment for Part II began September 2019, with expected completion by the end of 2021. Conclusion: Pulsewatch aims to demonstrate that a smartwatch can be accurate for real-time AF detection, and that older stroke patients will find the system usable and will adhere to monitoring.http://www.sciencedirect.com/science/article/pii/S2666693621000633Atrial fibrillationCommercial wearable devicePhotoplethysmographyStroke |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Emily L. Dickson, BS Eric Y. Ding, MS Jane S. Saczynski, PhD Dong Han, BS Majaz Moonis, MD Timothy P. Fitzgibbons, MD, PhD Bruce Barton, PhD Ki Chon, PhD David D. McManus, MD, MSci, FHRS |
spellingShingle |
Emily L. Dickson, BS Eric Y. Ding, MS Jane S. Saczynski, PhD Dong Han, BS Majaz Moonis, MD Timothy P. Fitzgibbons, MD, PhD Bruce Barton, PhD Ki Chon, PhD David D. McManus, MD, MSci, FHRS Smartwatch monitoring for atrial fibrillation after stroke—The Pulsewatch Study: Protocol for a multiphase randomized controlled trial Cardiovascular Digital Health Journal Atrial fibrillation Commercial wearable device Photoplethysmography Stroke |
author_facet |
Emily L. Dickson, BS Eric Y. Ding, MS Jane S. Saczynski, PhD Dong Han, BS Majaz Moonis, MD Timothy P. Fitzgibbons, MD, PhD Bruce Barton, PhD Ki Chon, PhD David D. McManus, MD, MSci, FHRS |
author_sort |
Emily L. Dickson, BS |
title |
Smartwatch monitoring for atrial fibrillation after stroke—The Pulsewatch Study: Protocol for a multiphase randomized controlled trial |
title_short |
Smartwatch monitoring for atrial fibrillation after stroke—The Pulsewatch Study: Protocol for a multiphase randomized controlled trial |
title_full |
Smartwatch monitoring for atrial fibrillation after stroke—The Pulsewatch Study: Protocol for a multiphase randomized controlled trial |
title_fullStr |
Smartwatch monitoring for atrial fibrillation after stroke—The Pulsewatch Study: Protocol for a multiphase randomized controlled trial |
title_full_unstemmed |
Smartwatch monitoring for atrial fibrillation after stroke—The Pulsewatch Study: Protocol for a multiphase randomized controlled trial |
title_sort |
smartwatch monitoring for atrial fibrillation after stroke—the pulsewatch study: protocol for a multiphase randomized controlled trial |
publisher |
Elsevier |
series |
Cardiovascular Digital Health Journal |
issn |
2666-6936 |
publishDate |
2021-08-01 |
description |
Background: Atrial fibrillation (AF) is a common heart rhythm disorder that elevates stroke risk. Stroke survivors undergo routine heart rhythm monitoring for AF. Smartwatches are capable of AF detection and potentially can replace traditional cardiac monitoring in stroke patients. Objective: The goal of Pulsewatch is to assess the accuracy, usability, and adherence of a smartwatch-based AF detection system in stroke patients. Methods: The study will consist of two parts. Part I will have 6 focus groups with stroke patients, caretakers, and physicians, and a Hack-a-thon, to inform development of the Pulsewatch system. Part II is a randomized clinical trial with 2 phases designed to assess the accuracy and usability in the first phase (14 days) and adherence in the second phase (30 days). Participants will be randomized in a 3:1 ratio (intervention to control) for the first phase, and both arms will receive gold-standard electrocardiographic (ECG) monitoring. The intervention group additionally will receive a smartphone/smartwatch dyad with the Pulsewatch applications. Upon completion of 14 days, participants will be re-randomized in a 1:1 ratio. The intervention group will receive the Pulsewatch system and a handheld ECG device, while the control group will be passively monitored. Participants will complete questionnaires at enrollment and at 14- and 44-day follow-up visits to assess various psychosocial measures and health behaviors. Results: Part I was completed in August 2019. Enrollment for Part II began September 2019, with expected completion by the end of 2021. Conclusion: Pulsewatch aims to demonstrate that a smartwatch can be accurate for real-time AF detection, and that older stroke patients will find the system usable and will adhere to monitoring. |
topic |
Atrial fibrillation Commercial wearable device Photoplethysmography Stroke |
url |
http://www.sciencedirect.com/science/article/pii/S2666693621000633 |
work_keys_str_mv |
AT emilyldicksonbs smartwatchmonitoringforatrialfibrillationafterstrokethepulsewatchstudyprotocolforamultiphaserandomizedcontrolledtrial AT ericydingms smartwatchmonitoringforatrialfibrillationafterstrokethepulsewatchstudyprotocolforamultiphaserandomizedcontrolledtrial AT janessaczynskiphd smartwatchmonitoringforatrialfibrillationafterstrokethepulsewatchstudyprotocolforamultiphaserandomizedcontrolledtrial AT donghanbs smartwatchmonitoringforatrialfibrillationafterstrokethepulsewatchstudyprotocolforamultiphaserandomizedcontrolledtrial AT majazmoonismd smartwatchmonitoringforatrialfibrillationafterstrokethepulsewatchstudyprotocolforamultiphaserandomizedcontrolledtrial AT timothypfitzgibbonsmdphd smartwatchmonitoringforatrialfibrillationafterstrokethepulsewatchstudyprotocolforamultiphaserandomizedcontrolledtrial AT brucebartonphd smartwatchmonitoringforatrialfibrillationafterstrokethepulsewatchstudyprotocolforamultiphaserandomizedcontrolledtrial AT kichonphd smartwatchmonitoringforatrialfibrillationafterstrokethepulsewatchstudyprotocolforamultiphaserandomizedcontrolledtrial AT daviddmcmanusmdmscifhrs smartwatchmonitoringforatrialfibrillationafterstrokethepulsewatchstudyprotocolforamultiphaserandomizedcontrolledtrial |
_version_ |
1721207657932521472 |